Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Eckhardt

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Advances in Enzyme Regulation|January 1, 1976
Clinical pharmacology of carbohydrate derivatives with cytostatic potencyS Eckhardt
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1974
Evaluation of oncostatic agentsS Eckhardt
Antibiotics and Chemotherapy|January 1, 1978
Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafurS Eckhardt
Orvosi Hetilap|May 14, 1998
[The effect of docetaxel on malignant tumors]S Eckhardt
Orvosi Hetilap|December 9, 1973
[Current state of chemotherapy of tumor diseases]S Eckhardt
Orvosi Hetilap|September 10, 1995
[Use of taxol in the management of malignant tumors]S Eckhardt
Haematologica|April 1, 1972
Clinical pharmacology of dibromohexitolsS Eckhardt
Progress in Clinical and Biological Research|January 1, 1983
Clinical application and limitationS Eckhardt
Anti-Cancer Agents in Medicinal Chemistry|June 10, 2008
Tyrosine kinase inhibitors in cancer therapyS Eckhardt
Annals of the New York Academy of Sciences|November 5, 1997
Quality assurance of chemotherapyS Eckhardt
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Advances in Enzyme Regulation|January 1, 1976
Clinical pharmacology of carbohydrate derivatives with cytostatic potencyS Eckhardt
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1974
Evaluation of oncostatic agentsS Eckhardt
Antibiotics and Chemotherapy|January 1, 1978
Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafurS Eckhardt
Orvosi Hetilap|May 14, 1998
[The effect of docetaxel on malignant tumors]S Eckhardt
Orvosi Hetilap|December 9, 1973
[Current state of chemotherapy of tumor diseases]S Eckhardt
Orvosi Hetilap|September 10, 1995
[Use of taxol in the management of malignant tumors]S Eckhardt
Haematologica|April 1, 1972
Clinical pharmacology of dibromohexitolsS Eckhardt
Progress in Clinical and Biological Research|January 1, 1983
Clinical application and limitationS Eckhardt
Anti-Cancer Agents in Medicinal Chemistry|June 10, 2008
Tyrosine kinase inhibitors in cancer therapyS Eckhardt
Annals of the New York Academy of Sciences|November 5, 1997
Quality assurance of chemotherapyS Eckhardt
Pageof 16